You are not currently logged in.
Access JSTOR through your library or other institution:
Surveillance of Hospital-Acquired Central Line–Associated Bloodstream Infections in Pediatric Hematology-Oncology Patients: Lessons Learned, Challenges Ahead
Aditya H. Gaur MD MSc, David G. Bundy MD MPH, Cuilan Gao PhD, Eric J. Werner MD MMM, Amy L. Billett MD, Jeff D. Hord MD, Jane D. Siegel MD, David Dickens MD, Cindi Winkle RN CPON, Marlene R. Miller MD MSc and Children’s Hospital Association Hematology-Oncology Quality Transformation Collaborative Project
Infection Control and Hospital Epidemiology
Vol. 34, No. 3 (March 2013), pp. 316-320
Published by: Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Stable URL: http://www.jstor.org/stable/10.1086/669513
Page Count: 5
You can always find the topics here!Topics: Infections, Pathogens, Hospitals, Mucositis, Myeloid leukemia, Viridans Streptococci, Catheters, Blood, Neutropenia, Pediatrics
Were these topics helpful?See somethings inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Across 36 US pediatric oncology centers, 576 central line–associated bloodstream infections (CLABSIs) were reported over a 21-month period. Most infections occurred in those with leukemia and/or profound neutropenia. The contribution of viridans streptococci infections was striking. Study findings depict the contemporary epidemiology of CLABSIs in hospitalized pediatric cancer patients.
© 2013 by The Society for Healthcare Epidemiology of America. All rights reserved.